Citadel Advisors - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 30 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$84,000
+740.0%
62,343
+490.2%
0.00%
Q1 2020$10,000
-44.4%
10,563
-9.1%
0.00%
Q4 2019$18,00011,6240.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
BVF INC/IL 615,384$8,332,0001.29%
RTW INVESTMENTS, LP 250,000$3,385,0000.71%
Monashee Investment Management LLC 100,000$1,354,0000.57%
PARSONS CAPITAL MANAGEMENT INC/RI 275,728$3,733,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 175,000$2,370,0000.40%
TIEDEMANN ADVISORS, LLC 362,049$4,902,0000.36%
Morse Asset Management, Inc 63,700$862,0000.28%
Private Capital Advisors, Inc. 56,250$762,0000.25%
Crestline Management, LP 98,581$1,335,0000.18%
SECTORAL ASSET MANAGEMENT INC 112,500$1,523,0000.17%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders